Less than two years after scoring its first FDA clearance, Akili Interactive is betting big on its digital therapeutic technology. The Massachusetts-based company has signed a reverse-merger deal with ...

It’s been a tough year for makers of prescription digital therapeutics, many of whom have had to drastically cut staff—or even, in the case of Pear Therapeutics, completely shut down—to conserve ...

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTC Ⓡ (AKL-T01) as an over-the ...

Following its recent $30 million fundraise to advance its video game platform for neurological conditions such as attention deficit hyperactivity disorder and Alzheimer’s disease, Akili Interactive ...